Photo: Creative Commons / Rastatter

Swiss drugmaker Novartis said fourth-quarter core operating income rose 11 percent in constant currencies, as sales of its Entresto heart failure medicine accelerated along with revenue from its psoriasis-and-arthritis blockbuster Cosentyx. ...... read full story

Photo: Novartis in the Suurstoffi, Red Cross.

Ask about this article

Answer for your question of the article will be displayed here ...

Popular News Stories